On June 12, 2025, Ginkgo Bioworks Holdings, Inc. held its annual shareholder meeting where shareholders elected seven directors, ratified Deloitte & Touche LLP as auditors for 2025, and approved executive compensation. Approximately 78.27% of shares were represented, and all proposals passed with significant majority votes.